SeraCare Life Sciences Inc. (SRLS) announced today that the SEC has notified the company that it has completed its investigation of SeraCare and does not intend to recommend any enforcement action. According to the company, the investigation was initiated in 2005 while the company was under prior management and focused on the company’s financial statements filed with the SEC prior to Sept. 30, 2005.
‘Enforcement 40’ for 2020
Join Us On LinkedIn
Join the Securities Litigation and Enforcement Group on LinkedIn